<DOC>
	<DOCNO>NCT02410018</DOCNO>
	<brief_summary>This prospective , pilot , open-label , uncontrolled , safety effectiveness study uterine artery embolization OCL 503 woman leiomyomata schedule hysterectomy .</brief_summary>
	<brief_title>Safety Effectiveness OCL 503 Treatment Women With Leiomyomata</brief_title>
	<detailed_description>Patients allocate Cohort 1 Cohort 2 . Following pelvic angiogram delineate uterine vasculature , embolization procedure leave right uterine artery ( require ) perform patient , use OCL 503 embolic agent . Patients Cohort 1 proceed hysterectomy 1 week embolization , patient Cohort 2 undergo hysterectomy 1 month embolization . Tumor response , measure change leiomyomata size perfusion , determine MRI/MRA . Histology resect uterus conducted evaluate inflammatory response viable tumour tissue .</detailed_description>
	<mesh_term>Leiomyoma</mesh_term>
	<mesh_term>Myofibroma</mesh_term>
	<criteria>presence one follow symptom : abnormal menstrual bleeding , prolonged menstrual period , pelvic pain , bulkrelated symptom attribute uterine fibroid ( bulkrelated symptom include pelvic pressure , abdominal distension , abdominal bloating , constipation , backache , urinary frequency , urinary retention , ureteral dilation , rectal pressure ) , intensity uterine fibroidrelated symptom , sufficiently sever warrant hysterectomy , patient 's medical history , physical examination , result image ultrasound MRI ; age 30 55 year , inclusive ; pelvic examination gynaecologist within previous 6 month ; normal Pap smear within last 12 month ; endometrial biopsy within previous three six month , appropriate patient history ; premenopausal menstrual cycle last 22 35 day . An FSH value obtain within three month prior procedure must &lt; 40 IU/L ; schedule total abdominal hysterectomy ; willing able provide write , informed consent . treat GnRH agonist within previous 12 week ; ASA score â‰¥ 3 ; abnormally large ovarian artery , assess MRA determine Investigator ; undiagnosed pelvic mass outside uterus ; claustrophobia contraindication performance pre postprocedure MRI study include presence metal implant , metal plate , bone pin , bone screw , neurostimulators , cardiac pacemaker , aneurysm clip , cochlear retinal implant , permanent hearing aid , permanent eyeliner ; pedunculated subserosal fibroid attachment uterus less one third great diameter fibroid ; agree use contraceptive Visit 1 undergoing total abdominal hysterectomy ; compromise hematopoietic function ; hepatic dysfunction define liver function test 30 % upper limit normal ; active gynecologic systemic infection ; renal dysfunction define serum creatinine &gt; 1.5 mg/dL history gynecologic malignancy ; document anaphylactic reaction drug anesthetic , allergic reaction iodine contrast medium control antihistamine steroid ; receive investigational drug experimental therapy within past four week participate concurrent experimental therapy ; uterine volume &lt; 250 mL approximately &gt; 24 week gestation ; know endometrial hyperplasia , adenomyosis , pelvic inflammatory disease ; abnormal coagulation profile ; allergic bovine collagen ;</criteria>
	<gender>Female</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>June 2016</verification_date>
</DOC>